Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate
Antiviral defence type III CRISPR systems produce cyclic oligoadenylates (cOA) as second messengers that activate downstream effectors. Here the authors present the crystal structure of the type III CRISPR defence DNA nuclease Can1 in complex with cyclic tetra-adenylate (cA4) and show that Can1 nick...
Guardado en:
Autores principales: | Stephen A. McMahon, Wenlong Zhu, Shirley Graham, Robert Rambo, Malcolm F. White, Tracey M. Gloster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8e15c55ed2f04a3986e306637192568c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Activation and self-inactivation mechanisms of the cyclic oligoadenylate-dependent CRISPR ribonuclease Csm6
por: Carmela Garcia-Doval, et al.
Publicado: (2020) -
CRISPR technologies and the search for the PAM-free nuclease
por: Daphne Collias, et al.
Publicado: (2021) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
por: April Pawluk, et al.
Publicado: (2017) -
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
por: Matthew J. Johnson, et al.
Publicado: (2018) -
Efficient inter-species conjugative transfer of a CRISPR nuclease for targeted bacterial killing
por: Thomas A. Hamilton, et al.
Publicado: (2019)